Avanos Medical, Inc. (FRA:8HH)

Avanos Medical Statistics

Total Valuation

Avanos Medical has a market cap or net worth of EUR 462.38 million. The enterprise value is 516.75 million.

Market Cap	462.38M
Enterprise Value	516.75M

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	46.42M
Shares Outstanding	n/a
Shares Change (YoY)	-0.48%
Shares Change (QoQ)	+0.22%
Owned by Insiders (%)	2.13%
Owned by Institutions (%)	92.33%
Float	42.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.78
PB Ratio	0.70
P/TBV Ratio	2.07
P/FCF Ratio	7.24
P/OCF Ratio	5.20
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.85, with an EV/FCF ratio of 8.09.

EV / Earnings	-1.29
EV / Sales	0.86
EV / EBITDA	6.85
EV / EBIT	17.46
EV / FCF	8.09

Financial Position

The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.17.

Current Ratio	2.38
Quick Ratio	1.23
Debt / Equity	0.17
Debt / EBITDA	1.52
Debt / FCF	1.79
Interest Coverage	3.95

Financial Efficiency

Return on equity (ROE) is -46.68% and return on invested capital (ROIC) is 1.83%.

Return on Equity (ROE)	-46.68%
Return on Assets (ROA)	1.58%
Return on Invested Capital (ROIC)	1.83%
Return on Capital Employed (ROCE)	3.74%
Revenue Per Employee	267,860
Profits Per Employee	-179,454
Employee Count	2,227
Asset Turnover	0.51
Inventory Turnover	2.14

Taxes

Income Tax	-16.45M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.51% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-44.51%
50-Day Moving Average	9.78
200-Day Moving Average	10.81
Relative Strength Index (RSI)	55.52
Average Volume (20 Days)	88

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.68

Income Statement

In the last 12 months, Avanos Medical had revenue of EUR 596.52 million and -399.64 million in losses. Loss per share was -8.65.

Revenue	596.52M
Gross Profit	311.86M
Operating Income	29.32M
Pretax Income	-415.84M
Net Income	-399.64M
EBITDA	63.50M
EBIT	29.32M
Loss Per Share	-8.65

Balance Sheet

The company has 60.09 million in cash and 113.95 million in debt, giving a net cash position of -53.87 million.

Cash & Cash Equivalents	60.09M
Total Debt	113.95M
Net Cash	-53.87M
Net Cash Per Share	n/a
Equity (Book Value)	663.09M
Book Value Per Share	14.29
Working Capital	173.44M

Cash Flow

In the last 12 months, operating cash flow was 88.98 million and capital expenditures -25.14 million, giving a free cash flow of 63.84 million.

Operating Cash Flow	88.98M
Capital Expenditures	-25.14M
Free Cash Flow	63.84M
FCF Per Share	n/a

Margins

Gross margin is 52.28%, with operating and profit margins of 4.91% and -67.00%.

Gross Margin	52.28%
Operating Margin	4.91%
Pretax Margin	-69.71%
Profit Margin	-67.00%
EBITDA Margin	10.64%
EBIT Margin	4.91%
FCF Margin	10.70%

Dividends & Yields

Avanos Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.48%
Shareholder Yield	0.48%
Earnings Yield	-86.43%
FCF Yield	13.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Avanos Medical has an Altman Z-Score of 1.35 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.35
Piotroski F-Score	6